MSB 3.76% $1.03 mesoblast limited

Cell Therapy News/Articles, page-35

  1. 3,300 Posts.
    lightbulb Created with Sketch. 254
    Well yes, and no.

    If successful it will allow them to recover from the specific ailment, but guaranteed there will be another that will then assail them. We get old, things stop working, that costs money.

    At best you are just kicking the can down the road.

    Preventive medicine and general health, may in fact be just as cost effective as regenerative medicine in some or many instances. But, excercise and healthy eating doesn't make pharma money now, does it.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.